Process Validation - DR Asmaa El-Kersh, M.SC
Process Validation - DR Asmaa El-Kersh, M.SC
Importance Process
Definitions Objectives
of steps to be
of PV of PV
validation validated
We validate process to define & verify the proven acceptance ranges that
produce a product that will meet specification.
• The collection & evaluation of data, from the process design stage
through commercial production, which establishes scientific evidence
that a process is capable of consistently delivering quality product.
• All steps that are generally considered critical (medium & high risk steps)
should be monitored/scrutinized:
by summarizing actual process parameters applied & observations recorded
e.g. sifting stage, wet & dry granulation stages
observations serve as a feedback for future refinement of process parameters
• In Aug 2009, ICH released a guideline Q8R(2) (Step 4) to guide the industry in the
implementation of (QbD) in Section 3.2.P.2 (Pharmaceutical Development) for DPs
as defined in Module 3 of the CTD (ICH guideline M4).
New History of
Validation vs Current PV
approach PV
Qualification guidelines
of CPV
• QbD
• Risk management
Validation Qualification
Validation is establishing a documented Qualification is a process of assurance
evidence to provide a high degree of that the specific system, premises or
assurance that a specific system, equipment are able to achieve the
process or facility will consistently predetermined acceptance criteria, to
produce a product meeting its confirm the attribute that it claimed to
predetermined specifications & quality do.
attributes. It is documented evidence that a
specific piece of equipment, facility or
system is fit/ready for intended use.
Processes/Procedures (the way we use Equipment, Instruments & utility systems
things) are validated, e.g. cleaning, are qualified
manufacturing process & analytical
methods
Process
Importance Objectives
Definitions steps to be
of of PV
of PV validated
validation
Identification of
process variables
Stage 1 – Stage 2 –
Process Design Control strategy Process Qualification
Verification
Facility
Process
Design
Performance
Facility &
Qualification
Equipment
(PV)
Qualification
In control
Distribution Stage 3 –
to market CPV
Process
monitoring &
improvement
Process
Importance Objectives
Definitions steps to be
of of PV
of PV validated
validation
To proceed from stage 1 PC to stage 2 PQ, the following documents must be
completed and approved internally by the company:
Risk assessment to be carried out to link raw material attributes and process
parameters to CQAs, based on risk assessment control strategy shall be
designed and implemented.
2. Identify CQAs:
All quality attributes for the product should be evaluated by a company based on a quality target product
profile (QTPP). Potential CQAs should be identified based on an evaluation of the severity of the attribute
in terms of the impact, which is based on clinical experience and in-vitro studies.
5. Develop CPPs:
CPPs should be developed based on the knowledge gained during process development. CPPs should be
consistent with corresponding CQAs.
To proceed from stage 2 to stage 3: an approved report must be completed and
approved as well:
It Depends on:
Understanding the impact of variation on the process & ultimately on product attributes.
Controlling the variation in a manner corresponding to the risk it represents to the process &
product.
Process
Importance Objectives
Definitions steps to be
of of PV
of PV validated
validation
https://www.fda.gov/files/drugs/published/Process-Validation--General-Principles-and-Practices.pdf
• WHO Technical Report Series, No. 937, 2006 Annex 4 Supplementary guidelines on good manufacturing practices: validation
https://www.who.int/medicines/areas/quality_safety/quality_assurance/SupplementaryGMPValidationTRS937Annex4.pdf
• Annex 3 Guidelines on good manufacturing practices: validation, Appendix 7: non-sterile process validation
https://www.who.int/medicines/areas/quality_safety/quality_assurance/Annex3-TRS992.pdf?ua=1
• WHO Technical Report Series, No. 961, 2011 Annex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing
https://www.who.int/medicines/areas/quality_safety/quality_assurance/TransferTechnologyPharmaceuticalManufacturingTRS961Annex7.pdf?ua=1
• Guideline on process validation for finished products - information and data to be provided in regulatory submissions 21 November 2016 EMA/CHMP/CVMP/QWP/BWP/70278/2012-
Rev1,Corr.1
https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions_en.pdf
• EudraLex - Volume 4 Good manufacturing practice (GMP) Guidelines, Annex 15: Qualification and Validation
https://ec.europa.eu/health//sites/health/files/files/eudralex/vol-4/2015-10_annex15.pdf
• EudraLex - Volume 4 Good manufacturing practice (GMP) Guidelines, Annex 15: Qualification and Validation
https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-development-pharmaceutics_en.pdf
https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-11.pdf